Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Couch

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
The Journal of Infectious Diseases|April 6, 2006
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adultsJohn J Treanor, Gilbert M Schiff, Robert B Couch, et al.
BMC Infectious Diseases|August 1, 2014
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and olderRobert B Couch, José M Bayas, Covadonga Caso, et al.
The New England Journal of Medicine|March 30, 2002
Clinical responses to undiluted and diluted smallpox vaccineSharon E Frey, Robert B Couch, Carol O Tacket, et al.
The Journal of Infectious Diseases|March 2, 2011
Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humansKristine L Bucasas, Luis M Franco, Chad A Shaw, et al.
Vaccine|August 26, 2011
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccineRobert L Atmar, Wendy A Keitel, John M Quarles, et al.
Journal of Virology|October 9, 2015
Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseXinrong Tao, Tania Garron, Anurodh Shankar Agrawal, et al.
Journal of Clinical Microbiology|December 8, 2004
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptidePatrick C Y Woo, Susanna K P Lau, Beatrice H L Wong, et al.
The Journal of Infectious Diseases|February 15, 2007
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responsesRobert B Couch, Patricia Winokur, Kathryn M Edwards, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
The Journal of Infectious Diseases|April 6, 2006
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adultsJohn J Treanor, Gilbert M Schiff, Robert B Couch, et al.
BMC Infectious Diseases|August 1, 2014
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and olderRobert B Couch, José M Bayas, Covadonga Caso, et al.
The New England Journal of Medicine|March 30, 2002
Clinical responses to undiluted and diluted smallpox vaccineSharon E Frey, Robert B Couch, Carol O Tacket, et al.
The Journal of Infectious Diseases|March 2, 2011
Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humansKristine L Bucasas, Luis M Franco, Chad A Shaw, et al.
Vaccine|August 26, 2011
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccineRobert L Atmar, Wendy A Keitel, John M Quarles, et al.
Journal of Virology|October 9, 2015
Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseXinrong Tao, Tania Garron, Anurodh Shankar Agrawal, et al.
Journal of Clinical Microbiology|December 8, 2004
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptidePatrick C Y Woo, Susanna K P Lau, Beatrice H L Wong, et al.
The Journal of Infectious Diseases|February 15, 2007
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responsesRobert B Couch, Patricia Winokur, Kathryn M Edwards, et al.
Pageof 4